ACS Applied Materials & Interfaces · 2023 · 34 citations · 39 references
Natural SciencesMaterials EngineeringMaterials ScienceBiomedical OpticsNanomaterialsPhotonicsLuminescent MaterialsNanomedicinePhotochemistryPhotodynamic TherapyRadiation TherapyScintillator MaterialsCancer Photodynamic TherapyEmission SpectraIrradiation EffectsLuminescence LifetimeLuminescent NanomaterialsPersistent LuminescenceReactive Oxygen Species GenerationX-ray Irradiation
Persistent luminescence nanoparticle scintillators (PLNS) have been attempted for X-ray-induced photodynamic therapy (X-PDT) because persistent luminescence after ceasing radiation can make PLNS use less cumulative irradiation time and dose to generate the same amount of reactive oxygen species (ROS) compared with conventional scintillators to combat cancer cells. However, excessive surface defects in PLNS reduce the luminescence efficiency and quench the persistent luminescence, which is fatal to the efficacy of X-PDT. Herein, the PLNS of SiO 2 @Zn 2 SiO 4:Mn 2+, Yb 3+, Li + was designed by the energy trap engineering and synthesized by a simple template method, which has excellent X-ray and UV-excited persistent luminescence and continuously tunable emission spectra from 520 to 550 nm. Its luminescence intensity and afterglow time are more than 7 times that of the reported Zn 2 SiO 4:Mn 2+ used for X-PDT. By loading a Rose Bengal (RB) photosensitizer, an effective persistent energy transfer from the PLNS to photosensitizer is observed even after the removal of X-ray irradiation. The X-ray dose of nanoplatform SiO 2 @Zn 2 SiO 4:Mn 2+, Yb 3+, Li + @RB in X-PDT of HeLa cancer cells was reduced to 0.18 Gy compared to the X-ray dose of 1.0 Gy for Zn 2 SiO 4:Mn for X-PDT. This indicates that the Zn 2 SiO 4:Mn 2+, Yb 3+, Li + PLNS have great potential for X-PDT applications.
39
Frédéric Clabau, Xavier Rocquefelte, Stéphane Jobic et al. · Chemistry of Materials · 2005 · 705 citations